DexCom Inc. (DXCM)
Symbol Info
Listed Symbol DXCM
Name DexCom Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $1,031,600,000
Latest Fiscal EPS $-1.45
Price Info
21 Day Moving Average $154.0138
21 Day EMA $155.076810
50 Day Moving Average $158.2256
50 Day EMA $154.660370
200 Day EMA $141.802640
200 Day Moving Average 141.757680
52 Week High $178.45
52 Week Low $105.05
52 Week Change $18.118200
Alpha 0.025489
Beta 0.6318
Standard Deviation 0.139229
R2 0.024285
Periods 60
Share Information
10 Day Average Volume 739,092
20 Day Average Volume 675,517
30 Day Average Volume 778,782
50 Day Average Volume 811,743
Outstanding Shares 91,185,989
Float Shares 89,273,199
Percent Float 97.90%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 958
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 16,640,427
Institute Holdings Percent -
Institute Sold Previous 3 Months 14,645,899
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 13
Insider Holdings Percent 2.10%
Insider Sold Previous 3 Months 16
Insiders Shares Owned 1,912,790
Price Change
7 Day Price Change $1.5699921
7 Day Percent Change 1.01%
21 Day Price Change $8.4100040
21 Day Percent Change 5.66%
30 Day Price Change $-0.0099945
30 Day Percent Change -0.01%
Month To Date Price Change $7.6800
Month To Date Percent 5.15%
90 Day Price Change $3.529999
90 Day Percent Change 2.30%
Quarter To Date $7.679993
Quarter To Date Percent 5.15%
180 Day Price Change $42.629997
180 Day Percent Change 37.30%
200 Day Price Change $41.750000
200 Day Percent Change 36.25%
Year To Date $37.119995
Year To Date Percent 30.99%
Profile
Description Dexcom designs and commercializes continuous glucose monitoring (CGM) systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company sells three different pieces of equipment, a sensor, a transmitter, and a receiver.
Details
Issue Type CS
Market Cap $14,308,905,394
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 91,185,989
CEO Kevin R. Sayer
Employees 3,900
Last Audit UQ
Classification
CIK 0001093557
Industry Medical Diagnostics & Research
Sector Healthcare
NAICS Medical Laboratories(621511)
Info
Address 6340 Sequence Drive
San Diego, CA 92121
Website http://www.dexcom.com
Facisimile
Telephone +1 858 200-0200
Email investorrelations@dexcom.com
Key Ratios
Profitability
EBIT Margin -10.2
EBITDA Margin -7.1
Pre-Tax Profit Margin -10.7
Profit Margin Cont -22.74
Gross Margin 62.80
Profit Margin TOT -22.74
Income Statements
Revenue $954,900,000
Revenue Per Share $10.4720
Revenue 3 Years $21.55
Revenue 5 Years $33.83
Valuation Measures
PE Ratio -
Enterprise Value $13,317,096,998
Price To Sales 14.984716
Price To Free Cash 2,770.800000
PE High Last 5 Years -
Price To Book 19.7
Price To Cash Flow 80.1
PE Low Last 5 Years -
Price To Tangible Book 20.3
Financial Strength
Total Debt To Equity 1.6
Int Coverage -2.9
Current Ratio 6.1
Leverage Ratio 3.3
Quick Ratio 5.5
Long Term Debt To Capital 0.61
Assets
Receivables Turnover 2.4
Invoice Turnover 5.30
Assets Turnover 0.30
Management Effectiveness
Return Assets -11.1
Return On Equity -29.14
Return On Capital -10.89
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
DXCM
DexCom
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.